AXL and neoplasm: Inhibition of AXL using small molecule inhibitors or silencing AXL via short-hairpin knockdown systems was able to prevent tumour progression and to re-sensitise treatment-resistant cancer cells6–9, making it an emerging therapeutic target2,10.